This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Intervention for Smoking Cessation in Pre-Surgical Patients.

Sponsored by Hospital Universitari Vall d'Hebron Research Institute

About this trial

Last updated 2 years ago

Study ID

PR-483/2021

Status

Recruiting

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Started 2 years ago

What is this trial about?

The goal of this clinical trial is to assess efficacy of an intensive pre-surgical intervention to quit smoking in smoking patients who will be operated on implant orthopedic surgery or general and urological surgery. The main question[s] it aims to answer are: - Evaluate the efficacy of intensive pre surgical intervention to quit smoking compared to a brief intervention - Evaluate the implementation of this protocol. Participants will be randomized to 2 intervention groups (patients programmed for protesic implant orthopedic surgery in the first group, and general and urological surgery) and 2 control groups (stratified in the same manner as the intervention groups), and will be monitored through telematic check ups via phone calls.

What are the participation requirements?

Yes

Inclusion Criteria

- Patients must 18 years old or older, and be able to consent.

- Surgery programmed for at least 4 weeks after inclusion in the study.

- Smokers

No

Exclusion Criteria

- Pregnancy

- Already under treatment for smoking cessation

- Inability to consent due to cognitive impairment or language barrier.

- Non-primary knee or hip replacement surgery

- Participation in any study that forbids use of nicotine substitution therapy (dermal, oral)

Locations

Location

Status

Recruiting